Literature DB >> 15925707

Dietary cancer-chemopreventive compounds: from signaling and gene expression to pharmacological effects.

Chi Chen1, Ah-Ng Tony Kong.   

Abstract

The process of cancer development (carcinogenesis leading to advanced metastasized cancers) in humans generally takes many years through initiation, promotion and progression. Because advanced metastasized cancers are almost impossible to treat, cancer chemoprevention for the control and containment of early cancer development is highly desirable. Recent studies have provided strong evidence that many daily-consumed dietary compounds possess cancer-protective properties that might interrupt the carcinogenesis process. These properties include the induction of cellular defense detoxifying and antioxidant enzymes, which can protect against cellular damage caused by environmental carcinogens or endogenously generated reactive oxygen species. These compounds can also affect cell-death signaling pathways, which could prevent the proliferation of tumor cells. In this review, we will summarize current knowledge on dietary cancer-chemopreventive compounds and their induction of detoxifying enzymes and anti-proliferative effects, and discuss the challenges in translating these signaling and gene-expression events to pharmacological effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15925707     DOI: 10.1016/j.tips.2005.04.004

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  51 in total

1.  Expression patterns and action analysis of genes associated with physiological responses during rat liver regeneration: cellular immune response.

Authors:  Lian-Xing Zhang; Li-Feng Zhao; An-Shi Zhang; Xiao-Guang Chen; Cun-Shuan Xu
Journal:  World J Gastroenterol       Date:  2006-12-14       Impact factor: 5.742

Review 2.  Molecular mechanisms of Nrf2-mediated antioxidant response.

Authors:  Wenge Li; Ah-Ng Kong
Journal:  Mol Carcinog       Date:  2009-02       Impact factor: 4.784

Review 3.  Emerging applications of metabolomics in studying chemopreventive phytochemicals.

Authors:  Lei Wang; Chi Chen
Journal:  AAPS J       Date:  2013-06-22       Impact factor: 4.009

Review 4.  Nuclear factor-erythroid 2-related factor 2 as a chemopreventive target in colorectal cancer.

Authors:  Constance Lay Lay Saw; Ah-Ng Tony Kong
Journal:  Expert Opin Ther Targets       Date:  2011-01-25       Impact factor: 6.902

5.  Epigenetic blockade of neoplastic transformation by bromodomain and extra-terminal (BET) domain protein inhibitor JQ-1.

Authors:  Chengyue Zhang; Zheng-Yuan Su; Ling Wang; Limin Shu; Yuqing Yang; Yue Guo; Douglas Pung; Chas Bountra; Ah-Ng Kong
Journal:  Biochem Pharmacol       Date:  2016-08-09       Impact factor: 5.858

Review 6.  Interindividual differences in response to plant-based diets: implications for cancer risk.

Authors:  Johanna W Lampe
Journal:  Am J Clin Nutr       Date:  2009-03-18       Impact factor: 7.045

Review 7.  Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention.

Authors:  Ka Lung Cheung; Ah-Ng Kong
Journal:  AAPS J       Date:  2009-12-15       Impact factor: 4.009

8.  Synergistic antileukemic activity of carnosic acid-rich rosemary extract and the 19-nor Gemini vitamin D analogue in a mouse model of systemic acute myeloid leukemia.

Authors:  Ayelet Shabtay; Hagar Sharabani; Zeev Barvish; Michael Kafka; Doron Amichay; Joseph Levy; Yoav Sharoni; Milan R Uskokovic; George P Studzinski; Michael Danilenko
Journal:  Oncology       Date:  2008-10-14       Impact factor: 2.935

9.  MicroRNAs: New players in cancer prevention targeting Nrf2, oxidative stress and inflammatory pathways.

Authors:  Chengyue Zhang; Limin Shu; Ah-Ng Tony Kong
Journal:  Curr Pharmacol Rep       Date:  2015-01-11

10.  Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice.

Authors:  Siwang Yu; Tin Oo Khor; Ka-Lung Cheung; Wenge Li; Tien-Yuan Wu; Ying Huang; Barbara A Foster; Yuet Wai Kan; Ah-Ng Kong
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.